Oxidative Metabolism of Endocannabinoids by COX-2

E-ISSN： 1873-4286|10|6|659-667

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.6, 2004-02, pp. : 659-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 4, Iss. 3, 2004-09 ,pp. : 161-174

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoids

By Mechoulam R. Fride E. Di Marzo V.

European Journal of Pharmacology, Vol. 359, Iss. 1, 1998-10 ,pp. : 1-18

Elsevier

Access to resources Recommend Favorite

Comparison of the Effects of Nimesulide and Nimesulide-L-lysine on PGE₂ Production by COX-1 and COX-2 and on Chondrocyte Metabolism In-vitro

By de Leval X. Henrotin Y. Labasse A. Neven P. Delarge J. Somers F. Masereel B. Pirotte B.

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 2, 2000-02 ,pp. : 83-87

Pharmaceutical Press

Access to resources Recommend Favorite

COX-2 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. : 1465-1468

Informa Healthcare

Access to resources Recommend Favorite

COX-2 and the Kidneys

Current Pharmaceutical Design, Vol. 6, Iss. 17, 2000-11 ,pp. : 1737-1753

Bentham Science Publishers

Access to resources Recommend Favorite